SUBSCRIBE
SUBSCRIBE

Biohit has Been Granted a U.S. Patent for an Invention of Binding Carcinogenic Acetaldehyde in Gastrointestinal Tract and in Nutrition

October 16, 2012 | 
1 min read

Helsinki Stock Exchange, 2012-10-16 17:00 CEST (GLOBE NEWSWIRE) -- Biohit Oyj, Stock exchange Release 16th October 2012, at 18:00 EET - Biohit Oyj has been awarded US patent 8,227,513 B2, which is valid until 3.4.2026.

Europe
MORE ON THIS TOPIC
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Manufacturing
Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion, $200M Plant Purchase
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Sanofi's Distribution Center in Quebec, Canada
Radiopharmaceuticals
Sanofi Inks $326M Radiopharma Deal With Orano
October 17, 2024
 · 
2 min read
 · 
Tristan Manalac